Fidelity Investments
INBX

Fidelity Investments’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Fidelity Investments’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,759
Closed -$61.5K – 5759
2024
Q1 		$61.5K Sell
1,759
-1,468,150
-100% -$53.5M ﹤0.01% 3482
2023
Q4 		$55.9M Sell
1,469,909
-47,686
-3% -$1.02M ﹤0.01% 1245
2023
Q3 		$27.8M Sell
1,517,595
-254,137
-14% -$5.32M ﹤0.01% 1467
2023
Q2 		$46M Buy
1,771,732
+162,705
+10% +$3.8M ﹤0.01% 1311
2023
Q1 		$30.4M Sell
1,609,027
-81,608
-5% -$1.9M ﹤0.01% 1439
2022
Q4 		$41.7M Sell
1,690,635
-68,820
-4% -$2.02M ﹤0.01% 1326
2022
Q3 		$31.6M Buy
1,759,455
+314,813
+22% +$5.68M ﹤0.01% 1433
2022
Q2 		$16.4M Sell
1,444,642
-1,219
-0.1% -$17.9K ﹤0.01% 1733
2022
Q1 		$32.2M Buy
1,445,861
+26,500
+2% +$676K ﹤0.01% 1578
2021
Q4 		$62M Sell
1,419,361
-26,806
-2% -$1.07M ﹤0.01% 1334
2021
Q3 		$48.2M Sell
1,446,167
-15,304
-1% -$466K ﹤0.01% 1426
2021
Q2 		$40.2M Sell
1,461,471
-103,511
-7% -$2.16M ﹤0.01% 1544
2021
Q1 		$31.4M Sell
1,564,982
-32,845
-2% -$959K ﹤0.01% 1598
2020
Q4 		$52.7M Sell
1,597,827
-147,199
-8% -$3.92M ﹤0.01% 1296
2020
Q3 		$31.4M Buy
+1,745,026
New +$31.6M ﹤0.01% 1380

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fidelity Investments's INBX Position: Q2 2024 in Review

Fidelity Investments sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 1,759 shares — an estimated $61.5K sold.

Fidelity Investments first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $62M in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Fidelity Investments reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 1,759 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $61.5K.
  • Fidelity Investments first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • Fidelity Investments's Inhibrx, Inc. Common Stock position peaked at $62M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.